BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 9, 1999
View Archived Issues
HAV vaccine prevents secondary hepatitis A infection
Read More
ACE gene insertion/deletion polymorphism: therapeutic implications for ACE inhibitor therapy
Read More
Fluvastatin associated with beneficial effects in CAD patients with low HDL cholesterol levels
Read More
Company Profile: Northwest Biotherapeutics
Read More
A novel antiarrhythmic mechanism explored
Read More
Valaciclovir reduces CMV in kidney transplant recipients
Read More
Novel marine metabolite has antiinflammatory properties
Read More
Novel antitumor agents from Minophagen with an imidazo[1,5-a]pyrimidine structure
Read More
DiagnoCure extends agreement with Organon Teknika to all cancers
Read More
New use for an old drug: doxycycline in the treatment of abdominal aortic aneurysms
Read More
Unimed in discussions to sell stock
Read More
GlycoDesign seeks partners to advance the development of GlcNAc-TV enzyme inhibitors
Read More
Academic researchers move closer to the development of an artificial pancreas
Read More
Phase III study supports efficacy and safety of Hextend in treatment of hypovolemia
Read More
FDA approves IND for Adolor's novel analgesic
Read More
Behavioral effects of NOS inhibitor studied in rat model
Read More
3-D structure of MMP-2 published
Read More
New antitumor agents from Agouron acting as inhibitors of cyclin-dependent kinases
Read More
Taisho prepares new macrolide antibiotics active against sensitive and resistant bacteria
Read More
Selective alpha2-adrenoceptor antagonists developed at Pierre Fabre for neurodegenerative disorders
Read More
First launches announced for Asta Medica's LHRH antagonist
Read More
Ortho-McNeil presents basic research in the area of motilin antagonists
Read More
Protein kinase inhibitors from Glaxo for proliferative, metabolic and inflammatory disorders
Read More
Anticonvulsant isoquinoline series described in recent patent literature by SmithKline Beecham
Read More
Novel anticonvulsants designed by Howard University scientists
Read More
Novel rheumatic disease treatment strategy discussed at EULAR congress
Read More
Widely used antipsychotic drug under study for potential in RA
Read More
Interim results presented at EULAR from phase I trial of IDEC-131
Read More